Pharmaceutical Packaging Market worth $251.6 billion by 2034 - Exclusive Report by The Research Insights
CHICAGO, May 13, 2025 /PRNewswire/ -- The global Pharmaceutical Packaging Market is projected to be valued at US$ 139.2 billion in 2024 and reach USD 251.6 billion by 2034, growing at a CAGR of 6.1% according to a new report by The Research Insights. The market for pharmaceutical packaging is driven by the rising demand for adoption of branded and generic medicines in emerging economies across the globe which have propelled the demand for its packaging.
Market Overview and Growth Trajectory:
Pharmaceutical Packaging Market Growth: According to an exhaustive report by The Research Insights, the Pharmaceutical Packaging Market is experiencing significant growth, driven by the increasing focus on environmental sustainability is transforming various industries including the pharmaceutical packaging market. Because consumers along with governmental bodies and healthcare providers prioritize sustainable practices more than ever before they now seek packaging solutions that serve environmental health in addition to their functional purpose. Biodegradable films along with recyclable blister packs and paper-based secondary packaging solutions together with refillable container systems are becoming more popular. The pharmaceutical packaging market valued at US$ 139.2 billion in 2024, is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.1% during 2025–2034.
For More Information and To Stay Updated on The Latest Developments in The Pharmaceutical Packaging Market, Download The Sample Pages: https://www.theresearchinsights.com/request_sample?id=10035
Escalating the Role of Packaging in Modern Healthcare: The smart healthcare industry's constant evolution has positioned patient safety and drug integrity at the forefront while recognizing packaging as an essential element in fulfilling this mission. The pharmaceutical packaging market adapts to urgent demands for protection against medication contamination, tampering risks and human mistakes. International health authorities and governments have enforced strict regulatory measures aimed at protecting pharmaceutical supply chains. From the U.S. FDA's Drug Supply Chain Security Act to Europe's Falsified Medicines Directive, the message is clear: Product packaging needs to perform beyond containment functions by verifying product authenticity and safeguarding user safety and correct usage. Manufacturers are swiftly incorporating tamper-evident seals together with anti-counterfeit packaging and child-resistant features into their packaging production lines. Healthcare providers demand packaging solutions that reduce risks when medications are dispensed and administered. Accurate dosing blister packs and contamination-reducing prefilled syringes along with real-time product information smart labels are now more prevalent. The pharmaceutical packaging market growth that focuses on security and usability so drugs reach patients safely and maintain effectiveness.
E-commerce Boom Redefines Expectations in the Pharmaceutical Packaging Market: The growth of e-commerce and direct-to-patient healthcare models transforms medicine delivery and creates new requirements for pharmaceutical packaging market. The expanding use of online pharmacies for delivering prescriptions to patients' doorsteps means packaging now functions as an essential component of the healthcare experience. Modern consumers demand identical convenience and security standards for healthcare deliveries compared to their expectations from any online transaction. But pharmaceuticals come with unique challenges: Due to their temperature sensitivity and the need for tamper-proof protection pharmaceuticals must reach their destination intact and punctually. The pharmaceutical packaging market size is rapidly developing to fulfil stringent requirements of the sector. Insulated mailers and smart packaging solutions that monitor temperature in real-time have gained significant popularity because biologics, vaccines, and specialty drugs demand strict temperature control. The pharmaceutical packaging market needs to accelerate innovation at unprecedented rates to adapt to the demands of this new reality.
Stay Updated on The Latest Pharmaceutical Packaging Market Trends: https://www.theresearchinsights.com/request_sample?id=10035
Diverse Drug Delivery Formats Shaping the Future of the Pharmaceutical Packaging Market: Modern therapeutic advances have resulted in various drug delivery formats which create specialized packaging requirements and potential opportunities for pharmaceutical packaging market. The field of ophthalmic drug delivery requires sterile packaging that delivers exact doses through single-use droppers and preservative-free multi-dose systems to protect patients from microbial contamination. Advanced packaging formats like prefilled syringes, vials, and ampoules with tamper-evident seals and temperature-resistant properties maintain drug integrity during storage and transport for injectable and IV drugs used in biologics and oncology treatments. The increasing use of nasal drug delivery for local and systemic treatments, such as vaccines and emergency medications demands the creation of unit-dose or metered-dose spray packaging which supports both easy administration and patient adherence. Effective wound care packaging requires both sterile conditions and easy access which is achieved by medical-grade pouches along with barrier films and reclosable packs for clean repeated usage. The field of pulmonary drug delivery for respiratory conditions is advancing inhaler packaging and dosing systems that guarantee precise administration and enhance patient adherence through innovative designs.
Geographical Insights: The pharmaceutical packaging market is primarily dominated by North America which produces 39% of total global revenue. The region's advanced healthcare infrastructure combined with substantial investments in drug development and the establishment of major pharmaceutical companies drives its market dominance. The European region stands as the second-largest pharmaceutical packaging market with Germany, the United Kingdom, and Italy stand as major contributors to this market due to their solid regulatory systems combined with their strong emphasis on research and development. The Asia-Pacific market stands as the third-largest region in terms of market share which amounts to about 19%. The fast-paced growth of the pharmaceutical industry results from improved healthcare knowledge among populations combined with higher disposable incomes and major investments in pharmaceutical production facilities particularly located in China and India.
Pharmaceutical Packaging Market Segmentation and Geographical Insights:
Based on material, the market is divided into plastic, glass, paper & paperboard, metal and others. The plastic segment held the largest share of the pharmaceutical packaging market in 2024.
Based on packaging format, the market is divided into bottles, vials & ampoules, blister packs, syringes, bags & pouches, sachets & stick packs, cartridges, boxes & cartons and other packaging formats. The bottles segment held the largest share of the pharmaceutical packaging market in 2024.
Based on drug delivery, the market is divided into ophthalmic, injectable, iv drugs, nasal, wound care, pulmonary, oral and others (topical and transdermal treatments). The oral segment accounted for a larger share of the pharmaceutical packaging market in 2024.
Based on end-use, the market is divided into pharma manufacturing, contract packaging, retail pharmacy and institutional pharmacy. The pharma manufacturing segment accounted for a larger share of the pharmaceutical packaging market in 2024.
The pharmaceutical packaging market is segmented into five major regions: North America, Europe, Asia Pacific, Central & South America and Middle East & Africa.
Purchase Premium Copy of Global Pharmaceutical Packaging Market Size and Growth Report (2025-2034) at: https://www.theresearchinsights.com/license?id=10035
Key Players and Competitive Landscape:
The Pharmaceutical Packaging Market is characterized by the presence of several major players, including:
Gerresheimer AG
Schott AG
Owens Illinois, Inc.
Amcor plc
Becton, Dickinson, and Company
AptarGroup, Inc.
West Pharmaceutical Services, Inc.
Ardagh Group S.A.
Smurfit WestRock
Comar, LLC
CCL Industries, Inc.
Vetter Pharma International
SGD Pharma
Bormioli Pharma S.p.A.
Klöckner Pentaplast
These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market.
For Region-Specific Market Data, Check Out Brief Sample Pages: https://www.theresearchinsights.com/request_sample?id=10035
Pharmaceutical Packaging Market Recent Developments and Innovations:
In April 2025, Gerresheimer AG collaborated with Injecto and launched their silicone-oil- and PFAS-free syringe systems which are made from glass and cyclic olefin polymer (COP). PFAS-free syringe systems can be used for ophthalmic applications and sensitive biologics.
In January 2025, Schott AG launched next generation polymer syringe system which provides tamper evidence at individual syringe level. The integrated label concept, developed with Schreiner MediPharm, offers reliable first-opening indication, oxygen and light protection, and can include an RFID chip for accurate drug traceability and inventory management.
In October 2024, Bormioli Pharma S.p.A. partners with Chiesi Group for providing their first pharma primary packaging in carbon capture PET bottles. Carbon Capture PET bottles provide a 21.9% decrease in kg of CO2 eq compared to traditional PET.
Conclusion:
The pharmaceutical packaging market size is experiencing major changes as global healthcare trends and regulatory pressures combine with growing complexity in drug formulations. The rising popularity of e-commerce and direct-to-patient models together with biologics development requires packaging solutions that maintain safety standards while providing temperature management and supply chain traceability. The movement toward sustainable packaging solutions that support global circular economy objectives drives research into biodegradable, recyclable and refillable materials development. The variety of drug delivery methods including injectables and IV medications together with pulmonary and nasal routes leads to a need for specialized packaging solutions to match different dosage types. The pharmaceutical industry prioritizes patient safety and compliance which leads to the adoption of smart labels, prefilled devices and child-resistant technologies as standard features.
Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: https://www.theresearchinsights.com/Ask_For_Customization?id=10035
The report from The Research Insights, therefore, provides several stakeholders—including raw material suppliers, contract pharma manufacturers, and end users —with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities.
With projected growth to US$ 251.6 billion by 2034, the Pharmaceutical Packaging Market represents a significant opportunity for raw material suppliers, packaging convertors, end-users, investors, industry stakeholders, and others. By staying abreast of market trends, embracing innovation, and focusing on quality and performance, companies can position themselves for success in this dynamic and evolving market landscape.
Related Report Titles:
Pharmaceutical Packaging Equipment Market Size, Share & Trends Analysis Report
Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report
Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends
Vials And Ampoules Market Size, Share & Trends Analysis Report
Small Volume Parenteral Market Size, Share & Trends Analysis Report
About Us:
The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions.
Contact Us:If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Kaushik RoyE-mail: sales@theresearchinsights.comPhone: +1 312-313-8080Website: https://www.theresearchinsights.com/
Logo: https://mma.prnewswire.com/media/2684869/The_Research_Insights_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/pharmaceutical-packaging-market-worth-251-6-billion-by-2034---exclusive-report-by-the-research-insights-302453600.html
SOURCE The Research Insights
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
13 minutes ago
- Associated Press
Global Times: At Rizhao Port: Small phone screen unlocks code to transform, upgrade China's global trade
BEIJING, June 9, 2025 /PRNewswire/ -- In the sunlit repair depot of Rizhao Port of Shandong Port Group, Xu Guannan stands in front of a giant 17-ton wheel loader. This beast of a machine, capable of lifting 3 cubic meters of coals in one scoop, is not humming well these days, sending its work efficiency down. Initial reports suggest the machine is hit by overheating problems, but dozens of parts could be the culprit. A traditional repair work would by this time start climbing this behemoth and try to scout for faulty parts, guided by hunches and experience. Instead, Xu, deputy head of the Technology Innovation Center of Rizhao Port, reached into his pocket to grab his smartphone. From the small screen, Xu accessed the interface of a digital repair manual developed by his team of software engineers and powered by the latest artificial intelligence (AI) tool DeepSeek, which analyzed the problem in a flash and gave the answer - a ventilation valve on the gearbox is at fault. This is just a snapshot of the high-tech-powered, smart operation of Rizhao Port, which has earned the highest praise for its successful transformation and upgrade over the years. On the afternoon of May 22, 2024, Xi Jinping, general secretary of the Communist Party of China Central Committee, Chinese president and chairman of the Central Military Commission, visited Rizhao Port, the Xinhua News Agency reported at the time. Xi said that Rizhao Port, as a new port after China's reform and opening-up drive, has transformed itself from a traditional port into a modern one through scientific and technological innovation in recent years. It has not only made the cargo throughput among the forefront of the country, but also accumulated experience in developing new quality productive forces through the transformation and upgrading of traditional industries, which is worthy of praise, Xi said, according to Xinhua. Currently, as global trade has encountered profound turbulence due to rising unilateralism and protectionism in certain parts of the world, China's focus on building modern ports and developing new quality productive forces underscore its unwavering commitment not only to high-quality development at home, but also to mutually beneficial trade with the rest of the world. This is also the underlying logic of China's development of the port economy: Let the world share China's opportunities. China is committed to building world-class ports to expand its 'circle of friends' of trading partners, contributing to the stability of global supply chains. 'Chinese model' Such a commitment translates into real action at Rizhao Port: autonomous trucks glide across the docks, guided by AI precision; Towering cranes, controlled remotely from a sleek command center, dance in perfect sync, unloading megaships with balletic grace. Behind this futuristic symphony of machines working seamlessly together are years of dedicated efforts to transform this once modest port into a high-tech titan, earning accolades as a 'Chinese model' for the transformation and upgrading of traditional terminals into fully automated container terminals worldwide. For Xu and his team, that means harnessing the country's latest technological advancements to empower the port's operation. Since last year, Xu's team sorted out and compiled a total of 400,000 paper maintenance log entries in the past 10 years for the port's dozens of wheel loaders and made all the information digitalized into a knowledge graph. 'In a way, we perpetuated old repair masters' wisdom through digitalization and AI,' Xu told the Global Times. The adoption of large language model is just one facets of the port's efforts in harnessing the hardcore power of technology to empower the port's smart operations. Tian Zhendong, a first-grade technician at the Technology Innovation Center of Rizhao Port of Shandong Port Group and a holder of the National May 1 Labor Medal, works at the port's 100-million-ton dry bulk cargo terminal. The terminal handles the transportation and storage of over 70 types of cargo across five major categories. Following recent technological upgrades, it is now home to over 80 sets of automated equipment across 10 major categories and operators control these machines from an office building located thousand meters away. In addition to remotely control portal cranes, a total of 24 industrial robots were employed to do the heavy and dirty job of cleaning coal-carrying rail cars and removing sticky coke. This solution alone has greatly improved unloading efficiency and slashed labor cost by 70 percent, Tian said. 'Our attitude toward automation is: once it's installed, we must use it. If we don't use it, we can't discover problems to help improve the system, and we can't truly enjoy the high efficiency automation brings,' Tian told the Global Times. Such a devotion from Tian and other workers at the port helped build the world's first parallel, open and fully automated container terminal, which handles about 6 million TEUs a year with dozens of operator-less ship-to-shore (STS) container cranes and automated guided vehicles (AGVs) working in harmony around-the-clock. The automation resulted in a single machine efficiency boost by 50 percent and reduction in overall cost by 70 percent, according to Rizhao Port authorities. Green development Smart operation is just one aspect of Rizhao Port's transformation witnessed by Tian, who started working at the port in 1989 and a second-generation port worker. His father participated in the construction of Rizhao Port in the 1980s, witnessing the port's transformation from a small fishing village on the East China Sea coast into a major coal port in China. 'In the past, city residents who live nearby the port area can tell the main cargo being transported in the port in a given period by the color of the powder dust clinging on their windows - red is iron and black is coal,' Tian said. One defining moment of the port's history, Tian recalled, is a State Council guideline policy in 2022 stipulating support for Rizhao Port to become a smart and green demonstration port for bulk dry cargo. 'With the emphasis on ecological protection in the past decade and dedicated efforts in greening the port's operation area, we have a cleaner port and a cleaner city nowadays,' Tian said, 'The theme color of Rizhao Port's story has changed from one of red and black to one featuring green and blue.' Ultimately, efforts to ensure smart and green operations are aimed at bolstering Rizhao Port's core function of handling cargoes. And in that regard, the port has also seen remarkable achievements: the port is the world's youngest port achieving an annual throughput of 500 million tons; it ranks first in China in the throughput of seven types of goods, including iron ore, soybeans, petroleum and coke; and it has become a vital port supplying raw materials and bulk commodities to the 'World's Factory.' Powering exports During the visit to Rizhao Port in May 2024, Xi learned about the local progress in promoting the smart and green development of the port, and expanding the opening-up, according to Xinhua. Rizhao Port's transformation is aimed at not only supporting the country's high-quality development, but also promoting high-level opening-up. The point of having a world-class port lies in serving world-class trade, as some workers at Rizhao Port told the Global Times. In recent years, companies in and around Rizhao city have seized the opportunity to advance port-industry-city integration and leveraged the port's shipping links with more than 100 countries and regions. Rizhao Port served as a vital link efficiently bridging production resources with global demand and effectively facilitating the global expansion of more 'Made in China' products. Wuzheng Group, a major player in China's agricultural and commercial vehicle industry located in the nearby Wulian county, offers a prime example. Rizhao Port's advantages in land transportation, efficiency, and marine transportation costs have provided the company with efficient, economical, and reliable logistics services, giving its overseas businesses a high-quality boost, according to Liang Yong, head of the company's international cooperation department. 'A three-wheeled vehicle, great at traversing inferior roads, is produced every three minutes on average at our plant and most are sold overseas to countries in Africa, including Ghana, Burkina Faso and Tanzania,' Liang Yong, head of the company's international cooperation department, told the Global Times. In May, Wuzheng Group exported 1,000 diesel-powered tricycles customized for West African mining areas through Rizhao Port, setting a new record for a single shipment of Chinese diesel tricycles to Africa. Behind that number is real stories of how 'Made in China' products changing lives in countries and regions. Liang said that many African customers told him how the three-wheeled vehicles changed their lives and help them pursue better a life. Wuzheng Group is hardly alone in leveraging the advantages offered by Rizhao Port to expand exports. Rizhao Yulan Intelligent Manufacturing Industrial Park, which is located just 15 kilometers from the port area, is also one of the companies utilizing the resources brought by the Rizhao Port. The company's highly automated plant transforms steel rolls into tinplate, a premium product having great overseas demand for its use in the making of cans used for storing fast-moving consumer goods like infant formula and beverages. 'Most of Shandong's steel production occurs near Rizhao, where our facility is based,' Wang Dawei, deputy general manager of Rizhao Yulan New Materials Co, 'This grants us access to low-cost raw materials. At the same time, we benefit from the port's extensive shipping routes, facilitating our global exports.' With over 80 container shipping routes from Rizhao and over 360 shipping routes of Shandong Port Group, Rizhao Port is a major node in the New Eurasian Land Bridge Economic Corridor as well as an important link of the Belt and Road Initiative. In addition to more destinations of exports, the types of goods shipped from Rizhao have also expanded to include new products such as new-energy vehicles (NEVs). In March, a batch of NEVs from Rizhao Port were officially shipped, marking a leap in the port's business related to the 'new three' of China's tech-intensive and green exports - NEVs, photovoltaic products, and lithium batteries, according to local media reports. The development story of Rizhao Port provides a footnote for China's steadfast efforts to strengthen its connection and exchanges with the rest of the world despite rising unilateralism and protectionism. Building world-class ports is one major aspect of those efforts, and China has made great strides - China is now home to eight of the world's top 10 busiest ports in terms of cargo throughput and seven of the world's top 10 ports in terms of container throughput, data from the Ministry of Transport showed. 'Port serves trade, and automation can make a port better. It is precisely this pragmatic attitude toward technological transformation that has enabled us to achieve what we have done so far and empowers our pursuit of a better tomorrow,' Xu said. View original content: SOURCE Global Times
Yahoo
18 minutes ago
- Yahoo
High Throughput Process Development Strategic Business Report 2025-2030: Increasing Focus on Speed and Efficiency in Drug Discovery Expands Market Opportunities
The global High Throughput Process Development (HTPD) market, pivotal for the biopharmaceutical industry, is projected to grow from $15.3 billion in 2024 to $24.6 billion by 2030, at a CAGR of 8.3%. Key drivers include technological innovations in automation and data analytics. The market is segmented by product types, including consumables and software, with major growth forecasted in regions such as China and the U.S. The report offers insights into market trends, regional analysis, and profiles leading companies like Agilent Technologies and Danaher Corporation. High Throughput Process Development Market Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "High Throughput Process Development - Global Strategic Business Report" report has been added to global market for High Throughput Process Development was valued at US$15.3 Billion in 2024 and is projected to reach US$24.6 Billion by 2030, growing at a CAGR of 8.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the High Throughput Process Development market. The growth in the high throughput process development market is driven by several factors, including the increasing complexity of biologic drugs, the rising demand for personalized medicines, and advancements in automation and data analytics. As the biopharmaceutical industry shifts toward more complex therapeutics, such as gene and cell therapies, the need for efficient process optimization is more critical than ever. HTPD allows companies to streamline the development of these therapies, reducing both time and costs. The growing demand for biosimilars, which require rapid process development to compete with branded biologics, is also contributing to market growth. Additionally, the adoption of automation and machine learning in process development is further enhancing the efficiency and accuracy of bioprocess optimization, driving the market's throughput process development (HTPD) is a critical tool in the biopharmaceutical industry, enabling faster, more efficient development of biologic drugs. HTPD involves the use of automated, miniaturized experiments that allow researchers to test multiple process conditions simultaneously, significantly accelerating the optimization of production processes for therapeutic proteins, vaccines, and monoclonal antibodies. The ability to screen numerous variables at once reduces the time and resources needed to scale up bioprocesses, from lab-scale to commercial manufacturing. As biopharmaceutical companies face increasing pressure to reduce costs and bring therapies to market faster, HTPD has become indispensable in ensuring both process efficiency and product Are Technological Innovations Shaping High Throughput Process Development?Technological innovations, particularly in automation, robotics, and data analytics, have revolutionized high throughput process development. Automation systems now allow for the simultaneous running of hundreds of experiments, enabling researchers to optimize cell culture conditions, purification processes, and formulation strategies more efficiently. The integration of advanced data analytics and machine learning into HTPD platforms has further enhanced process optimization, allowing for predictive modeling and real-time decision-making. Microfluidic technologies, which allow for the precise control of small volumes of liquids, are also playing a critical role in reducing reagent use and increasing the speed of bioprocess optimization. These technologies are enabling biopharmaceutical companies to streamline their development timelines and reduce production Do Market Segments Define the Growth of the High Throughput Process Development Market?Product types include consumables, software, and instruments, with consumables like reagents and microplates holding the largest market share due to their constant need in HTPD workflows. Services such as contract research and process development outsourcing are also expanding, as biopharmaceutical companies increasingly seek external expertise to accelerate drug development. The biopharmaceutical industry, particularly companies focused on biologics such as monoclonal antibodies, is the primary end-user of HTPD, as it enables rapid scale-up from R&D to manufacturing. Other key users include academic and research institutes involved in biotechnology Scope Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Agilent Technologies, Aurora Biomed, Axxam S.P.A., Bio-Rad Laboratories, Danaher Corporation and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Key Insights: Market Growth: Understand the significant growth trajectory of the Monoclonal Antibodies segment, which is expected to reach US$17.8 Billion by 2030 with a CAGR of a 9.1%. The Other Molecule Types segment is also set to grow at 6.5% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $3.9 Billion in 2024, and China, forecasted to grow at an impressive 12.6% CAGR to reach $6.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Segments Molecule Type (Monoclonal Antibodies, Other Molecule Types) Component (Tools & Systems, Consumables, Software, Other Components) Technology (Chromatography, Ultraviolet-Visible Spectroscopy, Other Technologies) End-Use (Biopharmaceutical Companies, Contract Research Organizations, Academic Research Institutes) Tariff Impact Analysis: Key Insights for 2025What's Included in This Edition: Tariff-adjusted market forecasts by region and segment Analysis of cost and supply chain implications by sourcing and trade exposure Strategic insights into geographic shifts Buyers receive a free July 2025 update with: Finalized tariff impacts and new trade agreement effects Updated projections reflecting global sourcing and cost shifts Expanded country-specific coverage across the industry Key Attributes: Report Attribute Details No. of Pages 89 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $15.3 Billion Forecasted Market Value (USD) by 2030 $24.6 Billion Compound Annual Growth Rate 8.3% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Influencer Market Insights Tariff Impact on Global Supply Chain Patterns Global Economic Update High Throughput Process Development - Global Key Competitors Percentage Market Share in 2024 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E) MARKET TRENDS & DRIVERS Rising Demand for Biopharmaceuticals Drives Growth in High Throughput Process Development Technological Advancements in Automation and Robotics Propel Innovation in High Throughput Process Development Increasing Focus on Speed and Efficiency in Drug Discovery Expands Addressable Market for High Throughput Solutions Growing Adoption of High Throughput Technologies in Vaccine Development Spurs Market Growth Surge in Demand for Personalized Medicine Strengthens Business Case for High Throughput Process Development Increasing Use of High Throughput Screening in Protein and Antibody Discovery Expands Market Potential Technological Innovations in Microfluidics and Lab Automation Propel Market Innovation Growing Focus on Reducing Time-to-Market for Pharmaceuticals Drives Adoption of High Throughput Processes Rising Use of Artificial Intelligence (AI) in High Throughput Data Analysis Strengthens Competitive Advantage Increasing Focus on Process Optimization and Scalability in Biopharmaceutical Production Drives Innovation Rising Demand for High Throughput Analytical Techniques in Quality Control Expands Market Opportunities FOCUS ON SELECT PLAYERS:Some of the 33 companies featured in this report Agilent Technologies Aurora Biomed Axxam S.P.A. Bio-Rad Laboratories Danaher Corporation Eppendorf GE Healthcare Hamilton Company Merck Millipore Perkinelmer Sartorius Stedim Biotech Tecan Group Thermo Fisher Scientific, Inc. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment High Throughput Process Development Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30 minutes ago
- Yahoo
Stock market today: S&P 500, Dow, Nasdaq futures stall with US and China set to reboot trade talks
US stock futures trod water on Monday ahead of renewed US-China trade talks in London, as investors watched for signs either side is willing to dial down tensions and reach a tariff deal. S&P 500 futures (ES=F) were little changed after the broad benchmark edged above 6,000 to notch its highest close since February. Dow Jones Industrial Average futures (YM=F) also fluctuated along the flat line, while contracts on the tech-heavy Nasdaq 100 (NQ=F) nudged 0.1% lower. Stocks ended last week on a high note, appearing to shake off the volatility that has plagued markets following President Trump's early-April tariff hikes. Encouraging jobs data helped ease fears of a recession fueled by his policy overhaul. Hopes are now for a breakthrough in the high-level US-China trade talks kicking off on Monday, after a phone call between Trump and Chinese President Xi last week. Read more: The latest on Trump's tariffs The stakes are high amid warnings that tariff barriers will harm economies worldwide — the US in particular. Investors are looking for a revival of the momentum shown in the Geneva pact in mid-May. Relations have soured since then, with the US and China accusing each other of not keeping to the trade truce and ratcheting up pressures in other areas. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
